Real-world retrospective review of monotherapy following platinum-based chemotherapy for metastatic urothelial cancer

OBJECTIVE: To compare estimated survival times of patients who had received maintenance monotherapy with gemcitabine (GEM), or an immuno-oncology (IO) drug (i.e., pembrolizumab or avelumab) or both therapies (one after the other) following platinum-based combination chemotherapy for metastatic uroth...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Hideaki, Obinata, Daisuke, Takada, Shogo, Yoshizawa, Tsuyoshi, Mochida, Junichi, Yamaguchi, Kenya, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226317/
https://www.ncbi.nlm.nih.gov/pubmed/37226460
http://dx.doi.org/10.1177/03000605231173319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226317/
https://www.ncbi.nlm.nih.gov/pubmed/37226460
http://dx.doi.org/10.1177/03000605231173319

Ejemplares similares